FY2025 · period end Dec '25 · from the 10-K filed Feb 12, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $21.11B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001058290-26-000025 | Jun 30, 2026 | Jul 10, 2026 | Jul 10, 2026 17:13 UTC | EDGAR |
| 8-K | 0001058290-26-000022 | Jun 2, 2026 | Jun 3, 2026 | Jun 3, 2026 20:07 UTC | EDGAR |
| 8-K | 0001058290-26-000020 | May 15, 2026 | May 21, 2026 | May 21, 2026 10:36 UTC | EDGAR |
| 8-K | 0001058290-26-000018 | May 17, 2026 | May 18, 2026 | May 18, 2026 12:05 UTC | EDGAR |
| 8-K | 0001058290-26-000015 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 10:49 UTC | EDGAR |
| 10-Q | 0001058290-26-000016 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 12:15 UTC | EDGAR |
| 8-K | 0001058290-26-000010 | Feb 23, 2026 | Feb 26, 2026 | Feb 26, 2026 12:36 UTC | EDGAR |
| 10-K | 0001058290-26-000008 | Dec 31, 2025 | Feb 12, 2026 | Feb 12, 2026 13:31 UTC | EDGAR |
Direct links to SEC EDGAR. CTSH has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Liabilities·As of Dec 31, 2014
Notable restatementwas$4B
Revised down in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Notable restatementwas$68.8M
Revised up in a 10-Q. Any P/OCF built on the original was 4.4% too high.
Liabilities·As of Dec 31, 2013
Notable restatementwas$2.1B
Revised down in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q2 2016
Notable restatementwas$428.4M
Revised up in a 10-Q. Any P/OCF built on the original was 2.2% too high.
Assets·As of Dec 31, 2014
Notable restatementwas$11.7B
Revised down in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q3 2016
Minor restatementwas$1B
Revised up in a 10-Q. Any P/OCF built on the original was 1.8% too high.
CTSH is not the only one.
See every restatement we've found across the market — or get an alert the next time CTSH revises a number.
Restatements are detected by comparing every vintage of a fact across all of COGNIZANT TECHNOLOGY SOLUTIONS CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CTSH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling COGNIZANT TECHNOLOGY SOLUTIONS CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CTSH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CTSH and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $19.35B |
| $19.43B |
| $18.51B |
| Gross Profit | $7.12B | $6.78B | $6.69B | $6.98B | $6.90B |
|---|
| Operating Income | $3.39B | $2.89B | $2.69B | $2.97B | $2.83B |
|---|
| Net Income | $2.23B | $2.24B | $2.13B | $2.29B | $2.14B |
|---|
| EPS (Diluted) | $4.56 | $4.51 | $4.21 | $4.41 | $4.05 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $20.69B | $19.97B | $18.48B | $17.85B | $17.85B |
| Total Liabilities | $5.68B | $5.56B | $5.26B | $5.54B | $5.86B |
| Stockholders' Equity | $15.02B | $14.41B | $13.23B | $12.31B | $11.99B |
| Cash & Equivalents | $1.90B | $2.23B | $2.72B | $2.29B | $1.79B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.88B | $2.12B | $2.33B | $2.57B | $2.50B |
| Capital Expenditures | $0.29B | $0.30B | $0.32B | $0.33B | $0.28B |
| Free Cash Flow | $2.60B | $1.83B | $2.01B | $2.24B | $2.22B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 33.7% | 34.3% | 34.6% | 35.9% | 37.3% |
| Operating Margin | 0.2% | 0.1% | 0.1% | 0.2% | 0.2% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 15.2% | 16.2% | 16.7% | 18.8% | 18.7% |
| Return on Assets | 11.0% | 11.7% | 11.7% | 12.8% | 12.3% |
| Debt / Equity | 0.04× | 0.06× | 0.05× | 0.05× | 0.06× |
